Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Lilly Contributes $10 Million to BioVeda China VC Fund

publication date: Jun 6, 2007
Fund Focused on Biomedical Companies in China -- BioVeda Capital, a Singapore-based venture capital firm, announced that Lilly Asia Ventures has made a $10 million investment into the BioVeda China fund. BioVeda China is the first international venture capital fund dedicated to making life science investments in China.BioVeda China will seek to identify companies that can become future industry leaders, transforming them into next-generation multinationals. More details...

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China